Paula Wethington is a digital producer at CBS Detroit. She previously held digital content roles at NEWSnet, Gannett/USA Today network and The Monroe News in Michigan. She is a graduate of the ...
At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
PGIM Ultra Short Bond ETF offers a ~4.23% SEC yield with ultra-short duration and investment-grade credit exposure and is rated Buy. PULS has consistently outperformed its ICE BofA US 3-Month Treasury ...
The NFL schedule has been released, so it's time to look ahead to the upcoming season and predict who's going to be competing in the postseason. Betting odds are available for the 2026 NFL campaign, ...
Using AI chatbots for even just 10 minutes may have a shockingly negative impact on people’s ability to think and problem-solve, according to a new study from researchers at Carnegie Mellon, MIT, ...
Apps that record visits are becoming popular, but they come with privacy and accuracy concerns. By Simar Bajaj At your next appointment, your doctor may have a new kind of assistant listening in: ...
A breakthrough in brain-inspired computing could make today’s energy-hungry AI systems far more efficient. Researchers have engineered a new nanoelectronic device using a modified form of hafnium ...
AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...
What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...
JERUSALEM — Israel will supply PULS rocket artillery systems to Greece for $750 million (€650 million), the Israeli Defense Ministry announced on Monday. The deal includes dozens of launchers and ...
This content can't be displayed right now. To view this embed, please accept targeting cookies. It's loaded from a third party and requires that permission to appear. Manage cookie preferences When ...